Key facts
- Notable investors include Yonghua Capital, Yijing Capital, Agency for Science, Med-Fine Capital, SunMed Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Aosheng
- ·The full record, as it builds
Funding rounds
No funding rounds for Aosheng are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aosheng
Manufacturer of a medical technology system designed to advance non-invasive diagnostics and surgical procedures. The company offers ultrasound-guided robotic systems, intelligent imaging, and real-time surgical navigation, enabling hospitals and healthcare providers to perform safer, precise, and minimally invasive treatments.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2019
- Employees
- 7
- Website
- ultrastmedtech.com/
- Ownership
- Privately Held (backing)
Aosheng doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aosheng shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aosheng in its N-PORT filings yet. We sweep new filings monthly.